Related Experiment Video
Updated: May 27, 2025

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Simple and Practical Way of Assessing Diastolic Function: Diastolic Heart Failure Revisited
Dae-Won Sohn1,2
1Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Insights
The term heart failure with preserved ejection fraction (HFpEF) is often used instead of diastolic heart failure (DHF). Current methods for assessing diastolic function are complex, necessitating simpler diagnostic approaches for better clinical trial and practice application.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- The term 'heart failure with preserved ejection fraction' (HFpEF) is now more common than 'diastolic heart failure' (DHF).
- HFpEF focuses on ejection fraction, overlooking the hemodynamic mechanisms crucial for understanding diastolic heart failure.
- Prognosis in HFpEF is primarily linked to underlying etiologies, complicating drug trial interpretations focused on survival benefits.
Purpose of the Study:
- To highlight the limitations of the term HFpEF in fully capturing the essence of diastolic heart failure.
- To advocate for a shift in focus for HFpEF studies towards specific etiologies and symptom improvement rather than survival.
- To underscore the clinical need for a simplified and practical method for assessing diastolic function.
Main Methods:
- Comparative analysis of terminology and diagnostic implications in heart failure research.
- Review of current recommendations for evaluating diastolic function.
- Discussion of challenges in applying complex diagnostic criteria in clinical trials and practice.
Main Results:
- The term HFpEF inadequately represents the multifaceted nature of DHF.
- Current diastolic function assessment guidelines are too complex for widespread clinical trial enrollment and daily practice.
- The lack of simple assessment tools hinders effective research and patient management in DHF.
Conclusions:
- Research and drug trials in HFpEF should focus on patients with confirmed diastolic dysfunction and prioritize symptom improvement.
- There is a significant clinical need for developing and implementing simpler, practical methods for assessing diastolic function.
- Revisiting the terminology and diagnostic approaches for diastolic heart failure is essential for advancing patient care and research.
Abstract:
Recently, usage of the term 'heart failure with preserved ejection fraction (HFpEF)' has predominated over the term 'diastolic heart failure (DHF).' The term 'preserved ejection fraction' represents only one aspect of DHF and does not provide insight into the hemodynamic mechanism of heart failure. In heart failure with reduced ejection fraction (HFrEF), depressed ejection fraction is the independent determinant of prognosis regardless of etiology. However, in HFpEF, because the prognosis is predominantly determined by etiologies of HFpEF, results of the drug on the prognosis in the clinical trial cannot be interpreted as it is. Therefore, studies on patients with HFpEF should be restricted to patients with diastolic dysfunction and, effects of drugs should be focused on symptom improvement not survival benefit. One reason for the prevalent use of HFpEF over DHF is the complexity in assessing diastolic function. Current official recommendations for the evaluation of diastolic function are too complex to be widely applied in the patient enrollment in large clinical trials as well as not easily applicable in our daily clinical practice. Therefore, there is a clinical need for a simple and practical way of assessing diastolic function.
More Related Videos
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023